APA (7th ed.) Citation

L, J., EH, C., P, F., J, K., K, V., M, M., . . . LO, J. (2022). Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 99(7), 1965. https://doi.org/10.1002/ccd.30175

Chicago Style (17th ed.) Citation

L, Jakobsen, et al. "Impact of Diabetes on Clinical Outcomes After Revascularization with the Dual Therapy CD34 Antibody-covered Sirolimus-eluting Combo Stent and the Sirolimus-eluting Orsiro Stent." Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions 99, no. 7 (2022): 1965. https://doi.org/10.1002/ccd.30175.

MLA (9th ed.) Citation

L, Jakobsen, et al. "Impact of Diabetes on Clinical Outcomes After Revascularization with the Dual Therapy CD34 Antibody-covered Sirolimus-eluting Combo Stent and the Sirolimus-eluting Orsiro Stent." Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions, vol. 99, no. 7, 2022, p. 1965, https://doi.org/10.1002/ccd.30175.